REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Feng Chi Biotech Corp. (Taiwan, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Feng Chi Biotech Corp. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Feng Chi Biotech Corp. is principally engaged in pre-implantation genetic testing, prenatal testing, life sciences, newborn screening, microbiological testing of food and pharmaceutical plants, and medical translational research. The company was founded in 1992 and is headquartered in Taiwan.

Headquarters
5F.-1, No.5, Shaoxing N.St., Zhongzheng Dist
Taipei City; Taipei City;

Contact Details: Purchase the Feng Chi Biotech Corp. report to view the information.

Website: http://www.fcbiotech.com.tw

Basic Information
Total Employees:
Purchase the Feng Chi Biotech Corp. report to view the information.
Outstanding Shares:
Purchase the Feng Chi Biotech Corp. report to view the information.
Financial Auditors:
Purchase the Feng Chi Biotech Corp. report to view the information.
Incorporation Date:
May 12, 1992
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
14.88%
Purchase this report to view the information.
3.68%
Purchase this report to view the information.
3.51%
Purchase this report to view the information.
2.99%
Purchase this report to view the information.
Subsidiaries
5.97
5.97%
4.41
4.41%
Company Performance
Financial values in the chart are available after Feng Chi Biotech Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-7.58%▼
Total operating revenue
-7.55%▼
Operating profit (EBIT)
-27.37%▼
EBITDA
-24.05%▼
Net Profit (Loss) for the Period
-26.37%▼
Total assets
-3.68%▼
Total equity
1.42%▲
Operating Profit Margin (ROS)
-3.46%▼
Net Profit Margin
-2.87%▼
Return on Equity (ROE)
-1.6%▼
Quick Ratio
0.49%▲
Cash Ratio
-0.17%▼

Similar companies

Ever Supreme Bio Technology Co., Ltd.
 
Energenesis Biomedical CO.,Ltd.
Great Novel Therapeutics Biotech & Medic
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo